Now showing items 402-421 of 446

    • Targeted screening of at-risk adults for acute HIV-1 infection in sub-Saharan Africa. 

      Sanders, Eduard J.; Wahome, Elizabeth.; Powers, Kimberly A.; Werner, Lise.; Fegan, Greg.; Lavreys, Ludo.; Mapanje, Clement.; McClelland, Scott.; Garrett, Nigel Joel.; Miller, William C.; Graham, Susan M. (Wolters Kluwer., 2015)
      Abstract available in pdf.
    • TB epidemiology: where are the young women? Know your tuberculosis epidemic, know your response. 

      Perumal, Rubeshan.; Naidoo, Kogieleum.; Padayatchi, Nesri. (BioMed Central., 2018)
      Abstract available in pdf.
    • TB treatment outcomes following directly-observed treatment at an urban outpatient specialist TB facility in South Africa. 

      Kharsany, Ayesha Bibi Mahomed.; Olowolagba, Ayo.; Abdool Karim, Salim Safurdeen.; Abdool Karim, Quarraisha.; Connolly, Catherine. (Sage., 2006)
      The treatment of 450 consecutive new patients with pulmonary TB was evaluated to determine outcome following directly-observed treatment. In all,176 (39.1%) patients were cured, 23 (5.1%) completed treatment, 80 (17.8%) ...
    • TB/HIV: an orphan disease? 

      Brust, James C. M.; O'Donnell, Max Roe.; Metcalfe, John Z. (American Thoracic Society., 2011)
      No abstract available.
    • Temporal association of HLA-B*81:01- and HLA-B*39:10-mediated HIV-1 p24 sequence evolution with disease progression. 

      Ntale, Roman.; Chopera, Denis Rutendo.; Ngandu, Nobubelo K.; de Assis Rosa, Debra.; Zembe, Lycias.; Gamieldien, Hoyam.; Mlotshwa, Mandla.; Werner, Lise.; Woodman, Zenda.; Mlisana, Koleka Patience.; Abdool Karim, Salim Safurdeen.; Gray, Clive M.; Williamson, Carolyn. (American Society for Microbiology., 2012)
      HLA-B*81:01 and HLA-B*39:10 alleles have been associated with viremic control in HIV-1 subtype C infection. Both alleles restrict the TL9 epitope in p24 Gag, and cytotoxic-T-lymphocyte (CTL)-mediated escape mutations in ...
    • Tenofovir gel for the prevention of herpes simplex virus type 2 infection. 

      Abdool Karim, Salim Safurdeen.; Abdool Karim, Quarraisha.; Kharsany, Ayesha Bibi Mahomed.; Baxter, Cheryl.; Grobler, Anna Christina.; Werner, Lise.; Kashuba, Angela D. M.; Mansoor, Leila Essop.; Samsunder, Natasha.; Mindel, Adrian.; Gengiah, Tanuja Narayansamy. (Massachusetts Medical Society., 2015)
      Abstract available in pdf.
    • Tenofovir-based preexposure prophylaxis for HIV infection among African women. 

      Marrazzo, Jeanne M.; Ramjee, Gita.; Richardson, Barbra A.; Gomez, Kailazarid.; Mgodi, Nyaradzo.; Nair, Gonasagrie.; Palanee, Thesla.; Nakabiito, Clemensia.; van der Straten, Ariane.; Noguchi, Lisa M.; Hendrix, Craig W.; Dai, James Y.; Ganesh, Shayhana.; Mkhize, Baningi.; Taljaard, Marthinette.; Parikh, Urvi M.; Piper, Jeanna.; Mâsse, Benoît.; Grossman, Cynthia.; Rooney, James.; Schwartz, Jill L.; Watts, Heather D.; Marzinke, Mark A.; Hillier, Sharon L.; McGowan, Ian M.; Chirenje, Zvavahera Mike. (Massachusetts Medical Society., 2015)
      Abstract available in pdf.
    • Time for gender mainstreaming in editorial policies. 

      Heidari, Shirin.; Eckert, Mirjam J.; Kippax, Susan.; Abdool Karim, Quarraisha.; Sow, Papa Salif.; Wainberg, Mark A. (International AIDS Society., 2011)
      The HIV epidemic has been continuously growing among women, and in some parts of the world, HIV-infected women outnumber men. Women’s greater vulnerability to HIV, both biologically and socially, influences their health ...
    • Timing of initiation of antiretroviral drugs during tuberculosis therapy. 

      Abdool Karim, Salim Safurdeen.; Naidoo, Kogieleum.; Grobler, Anna Christina.; Padayatchi, Nesri.; Baxter, Cheryl.; Gray, Andrew Lofts.; Gengiah, Tanuja Narayansamy.; Nair, Gonasagrie.; Bamber, Sheila.; Singh, Aarthi.; Khan, Munira.; Pienaar, Jacqueline C.; El-Sadr, Wafaa.; Friedland, Gerald H.; Abdool Karim, Quarraisha. (Massachusetts Medical Society., 2010)
      Background. The rates of death are high among patients with coinfection with tuberculosis and the human immunodeficiency virus (HIV). The optimal timing for the initiation of antiretroviral therapy in relation to tuberculosis ...
    • Topical microbicides - What's new? 

      Abdool Karim, Quarraisha.; Baxter, Cheryl.; Abdool Karim, Salim Safurdeen. (Lippincott Williams & Wilkins., 2013)
      Topical microbicides are an important, promising but complex HIV prevention technology under development. After 11 disappointing effectiveness trial outcomes of 6 candidate products (some tested as multiple doses and ...
    • Transmission networks and risk of HIV infection in KwaZulu-Natal, South Africa : a community-wide phylogenetic study. 

      De Oliveira, Tulio De Paiva Nazareth Andrade.; Kharsany, Ayesha Bibi Mahomed.; Gräf, Tiago.; Cawood, Cherie.; Khanyile, David.; Grobler, Anna Christina.; Puren, Adrian.; Madurai, Savathree.; Baxter, Cheryl.; Abdool Karim, Quarraisha.; Abdool Karim, Salim Safurdeen. (Elsevier., 2017)
      Abstract available in pdf.
    • Transmission of HIV-1 CTL escape variants provides HLA - mismatched recipients with a survival advantage. 

      Chopera, Denis Rutendo.; Woodman, Zenda.; Mlisana, Koleka Patience.; Mlotshwa, Mandla.; Martin, Darren Patrick.; Seoighe, Cathal.; Treurnicht, Florette K.; de Assis Rosa, Debra.; Hide, Winston.; Abdool Karim, Salim Safurdeen.; Gray, Clive M.; Williamson, Carolyn. (Plos., 2007)
      One of the most important genetic factors known to affect the rate of disease progression in HIV-infected individuals is the genotype at the Class I Human Leukocyte Antigen (HLA) locus, which determines the HIV peptides ...
    • Treatment and outcomes in children with multidrug-resistant tuberculosis: a systematic review and individual patient data meta-analysis. 

      Harausz, Elizabeth P.; Garcia-Prats, Anthony J.; Law, Stephanie.; Schaaf, H. Simon.; Kredo, Tamara.; Seddon, James A.; Menzies, Dick.; Turkova, Anna.; Achar, Jay.; Amanullah, Farhana.; Barry, Pennan.; Becerra, Mercedes.; Chan, Edward D.; Chan, Pei Chun.; Ioana Chiotan, Domnica.; Crossa, Aldo.; Drobac, Peter C.; Lee, Fairlie.; Falzon, Dennis.; Flood, Jennifer.; Gegia, Medea.; Hicks, Robert M.; Isaakidis, Petros.; Kadri, S.M.; Kampmann, Beate.; Madhi, Shabir A.; Marais, Else.; Mariandyshev, Andrei.; Méndez-Echevarría, Ana.; Moore, Brittany Kathryn.; Nargiza, Parpieva.; Ozere, Iveta.; Padayatchi, Nesri.; Ur-Rehman, Saleem.; Rybak, Natasha.; Santiago-Garcia, Begoña.; Shah, N. Sarita.; Sharma, Sangeeta.; Shim, Tae Sun.; Skrahina, Alena.; Soriano-Arandes, Antoni.; Van den Boom, Martin.; Van der Werf, Marieke J.; Van der Werf, Tjip S.; Williams, Bhanu.; Yablokova, Elena.; Yim, Jae-Joon.; Furin, Jennifer.; Hesseling, Anneke C. (Public Library of Science., 2018)
      Abstract available in pdf.
    • Treatment outcomes for extensively drug-resistant tuberculosis and HIV co-infection. 

      O'Donnell, Max Roe.; Padayatchi, Nesri.; Kvasnovsky, Charlotte.; Werner, Lise.; Master, Iqbal.; Horsburgh, Charles Robert. (U.S. National Center for Infectious Diseases., 2013)
      High mortality rates have been reported for patients co-infected with extensively drug-resistant tuberculosis (XDR-TB) and HIV, but treatment outcomes have not been reported. We report treatment outcomes for adult XDR TB ...
    • Trends in HIV prevalence in pregnant women in rural South Africa. 

      Kharsany, Ayesha Bibi Mahomed.; Fröhlich, Janet Ann.; Yende-Zuma, Fortunate Nonhlanhla.; Mahlase, Gethwana.; Samsunder, Natasha.; Dellar, Rachael C.; Zuma-Mkhonza, May.; Abdool Karim, Salim Safurdeen.; Abdool Karim, Quarraisha. (Wolters Kluwer., 2015)
      Abstract available in pdf.
    • Trial participation disclosure and gel use behavior in the CAPRISA 004 tenofovir gel trial. 

      Succop, Stacey M.; MacQueen, Kathleen M.; van Loggerenberg, Francois.; Majola, Nelisile.; Abdool Karim, Quarraisha.; Abdool Karim, Salim Safurdeen. (Succop, S.M., MacQueen, K.M., van Loggerenberg, F., Majola, N., Abdool Karim, Q. and Abdool Karim, S.S. 2014. Trial participation disclosure and gel use behavior in the CAPRISA 004 tenofovir gel trial. AIDS care 26(12), 1521-1525., 2014)
      Abstract available in pdf.
    • TRIM5α and TRIM22 are differentially regulated according to HIV-1 infection phase and compartment. 

      Singh, Ravesh.; Patel, Vinod.; Mureithi, Marianne W.; Naranbhai, Vivek.; Ramsuran, Duran.; Tulsi, Sahil.; Hiramen, Keshni.; Werner, Lise.; Mlisana, Koleka Patience.; Altfeld, Marcus.; Luban, Jeremy.; Kasprowicz, Victoria.; Dheda, Keertan.; Abdool Karim, Salim Safurdeen.; Ndung’u, Peter Thumbi. (American Society for Microbiology., 2014)
      The antiviral role of TRIM E3 ligases in vivo is not fully understood. To test the hypothesis that TRIM5α and TRIM22 have differential transcriptional regulation and distinct anti-HIV roles according to infection phase and ...
    • Tuberculosis treatment outcomes among peri-urban children receiving doorstep tuberculosis care. 

      Jeena, Lisha.; Naidoo, Kogieleum. (International Union against Tuberculosis and Lung Disease., 2016)
      Abstract available in pdf.
    • Understanding and responding to HIV risk in young South African women: clinical perspectives. 

      Dellar, Rachael C.; Waxman, Aliza M.; Abdool Karim, Quarraisha. (South African Medical Association., 2015)
      Abstract available in pdf.